TIMP1 and type 2 diabetes mellitus: In hypercholesterolemic patients with type 2 diabetes, elevated MMP-7 and MMP-8 concentrations were reduced by atorvastatin, along with their ratios to TIMP-1, through suppression of inflammatory mediators [16].